Supporting the first line of defense in a pandemic
Lateral flow assays are empowering the fight against COVID-19 and in this article, experts in the field tell us more about this technology, highlighting recent advances and challenges
Lateral flow assays are empowering the fight against COVID-19 and in this article, experts in the field tell us more about this technology, highlighting recent advances and challenges
This collaboration enables improved integration of software and robotics platforms to maximize COVID-19 testing throughput and efficiency
Catch up on this on-demand webinar and register for part 2 to learn everything you need to know to get ready for IVDR
Explore topics from immuno-oncology, Raman spectroscopy, in vitro diagnostics, and clinical research
The partnership will accelerate clinical validation and commercialization of certain NGS, mass spectrometry and immunology diagnostic tools
A response to the unprecedented global demand for key scientific resources
Therapy used for the treatment of certain patients with locally advanced or metastatic esophageal or gastroesophageal junction carcinoma
Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing
The assay has the ability to sequence and surveil evolution of virus mutations over time and geography
In this on-demand webinar, we look at ways to improve time to result in critical pathways such as sepsis
This study offers new insights into high grade serous ovarian cancer that have the potential to make an impact in how patients are treated in the future
Lenco Diagnostic Laboratories among first to offer Beckman Coulter’s semi-quantitative antibody test
Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall
The company is set to support the $12 billion expansion in COVID-19 testing as vaccinations increase
Explore topics from immunoassays, immunotherapeutics and immuno-oncology to Raman spectroscopy, metabolomics, and COVID-19
Explore our exclusive interviews and free resources to help support your cancer research, diagnostics, and therapy development
The cobas SARS-CoV-2 Variant Set 1 Test is designed to detect key spike mutations in virus variants associated with increased human-to-human transmission
Join thousands of scientists from around the world as they come together online to discuss the hottest topics and latest technology solutions
Explore topics from immunoassays and immunotherapeutics to high-sensitivity troponin assays, metabolomics, and in situ hybridization
Abbott will rapidly develop tests that can be used to help identify, isolate, and contain outbreaks when potential new virus threats are identified